Date Time
Ludwig Cancer Research scientists to present advances in immunotherapy, cancer metabolism
APRIL 10, 2021, NEW YORK – Ludwig Cancer Research released today the full scope of research to be presented by Ludwig-affiliated scientists at the April 9-14 American Association for Cancer Research (AACR) Annual Meeting, the first of two meetings which will be held online this year.
“The AACR Annual Meeting has long served as major opportunity for cancer researchers at all stages of their careers and from all over the world to meet, exchange ideas and forge collaborations to advance the study and treatment of cancer,” said Chi Van Dang, scientific director of the Ludwig Institute for Cancer Research and Editor-in-Chief of AACR’s Cancer Research journal. “The COVID-19 pandemic may have disrupted the physical gathering, but the intellectual exchange it enables will continue unimpeded. Ludwig and its scientists are excited about participating in that exchange.”
Asian Fund for Cancer Research Announces Inaugural BRACE Award Venture Competition Winner | Taiwan News
taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.
Cancer: a new killer lymphocyte enters the ring
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Winner of the AIM-HI Accelerator Fund’s Inaugural Women’s Venture Competition Announced
Share Article ROCKVILLE, Md. (PRWEB) February 22, 2021 Privo Technologies and its chief executive officer, Manijeh Goldberg, Ph.D., have been selected as the winner of the AIM-HI Accelerator Fund’s inaugural Women’s Venture Competition, a first of its kind program for female entrepreneurs starting oncology companies.
Privo Technologies has developed a nano-engineered platform for redesigning the mechanism of action of potent cancer medicines. The company was selected from among 47 female-led oncology start-ups following rigorous review and evaluation by three blue ribbon committees. As a result, Privo Technologies has received investment totaling $900,000 $300,000 from AIM-HI and matching investments from two supporters of the Women’s Venture Competition.